glp 1 agonist for pcos The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome Efficacy and safety of GLP-1
Description
doi: 10.1038/379069a0 198 TyeK
Expert Opin Pharmacother 2011;12:143951.ArticlePubMed 98
Moreover, data from post-marketing surveillance and large population-based studies, especially from the US, are limited
The study found that the average weight decreased by 10.05 kg after 3 months of treatment (40)
Relationship between intravenous use and achieving initial cocaine abstinence
